Psychiatry & Neurology Doctors in Guayama, PR Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Robert Rimpel-andre, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: Carr.3 Km 134.5, Bo. Algarrobo, Guayama, PR 00784 Phone: 787-840-2575    Fax: 787-840-8391

Carlos J. Gonzalez Degro, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: La Fuente Towncenter, Suite 11,119, Guayama, PR 00784 Phone: 787-866-4455    Fax: 787-866-1733

Dr. Armando Luis Perez De Jesus, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 128 Calle Ashford S, Ashford Medical Plaza Suite 102, Guayama, PR 00784 Phone: 787-866-0337    Fax: 787-866-0337

Jens Suero - Lora, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: Hospital Menonita De Guayama Suite 208, Ave. Pedro Albizu Campos, Urb. Lahacienda, Guayama, PR 00784 Phone: 787-864-4300

Geraldine Enid Batista Irizarry, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 109 Ave Pedro Albizu Campos, La Fuente Town Center, Guayama, PR 00784 Phone: 787-296-9777

News Archive

Pre-existing nutritional deficits, immune dysfunction may increase hepatitis E risk during pregnancy

Researchers from the Johns Hopkins Bloomberg School of Public Health have found a link between pre-existing nutritional deficits and immune dysfunction and the risk of hepatitis E infection during pregnancy.

Medicaid expansion making diabetes meds more accessible to poor, study shows

Low-income people with diabetes are better able to afford their medications and manage their disease in states that expanded Medicaid under the Affordable Care Act, a new study suggests.

Study shows antibiotic resistance in livestock has almost tripled since 2000

The growing appetite for animal protein in developing countries has resulted in a smorgasbord of antibiotic consumption for livestock that has nearly tripled the occurrence of antibiotic resistance in disease-causing bacteria easily transmitted from animals to humans, according to a recent report in the journal Science.

Eisai to seek marketing authorization for perampanel in the U.S. and EU

Eisai announced today that it will submit Marketing Authorization Applications in the United States and the European Union for the investigational compound perampanel (E2007) based on the results of three Phase III pivotal studies. Perampanel is a first-in-class, highly selective non-competitive AMPA-type glutamate receptor antagonist, discovered and being developed by Eisai for adjunctive treatment of partial onset seizures in patients with epilepsy.

Read more Medical News

› Verified 2 days ago